Company chiefs have been outlining its five-year plan in New York.
At the company's New York conference, which began at 10 pm Israel time today, Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) senior managers have begun to shed light on its strategic plan for the next five years.
Teva CEO Shlomo Yanai began with the bottom line. "By 2015, we expect sales of $31 billion and a profit of $6.8 billion 22% profitability," he announced.
In the previous plan, presented in 2008, the goal was 20/20 sales of $20 billion and a net profit margin of over 20% of sales in 2012. However, that plan was before Teva acquired Barr.
Published by Globes [online], Israel business news - www.globes-online.com - on January 7, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010